PR Newswire - SECuRE update: recruitment target of the Cohort Ex...
SYDNEY, Oct. 8, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...
Read More


ภาษาไทย
English